BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marinho RT, Giria J, Moura MC. Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005). World J Gastroenterol 2007; 13(10): 1522-1527 [PMID: 17461443 DOI: 10.3748/wjg.v13.i10.1522] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Nery F, Graca L, Ribeiro M, Guimaraes H, Miranda HP. Sorafenib Improves Survival in Metastatic Hepatocellular Carcinoma: A Case Report. World J Oncol 2010;1:213-7. [PMID: 29147210 DOI: 10.4021/wjon240w] [Reference Citation Analysis]
2 Ramos Rubio E. [Problems, question marks and controversies in liver transplantation due to hepatocarcinoma]. Cir Esp 2008;84:115-6. [PMID: 18783668 DOI: 10.1016/s0009-739x(08)72151-1] [Reference Citation Analysis]
3 Pinho I, Santos JV, Dinis-Ribeiro M, Freitas A. Burden of digestive diseases in Portugal: trends in hospitalizations between 2000 and 2010. Eur J Gastroenterol Hepatol 2015;27:279-89. [PMID: 25629572 DOI: 10.1097/MEG.0000000000000266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Carneiro de Moura M, Marinho R. [Natural history and clinical manifestations of chronic hepatitis B virus]. Enferm Infecc Microbiol Clin 2008;26 Suppl 7:11-8. [PMID: 19100227 DOI: 10.1016/s0213-005x(08)76515-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Magalhães-Costa P, Lebre L, Peixe P, Santos S, Chagas C. Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk Score. GE Port J Gastroenterol 2016;23:233-42. [PMID: 28868468 DOI: 10.1016/j.jpge.2016.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Vitor S, Marinho RT, Gíria J, Velosa J. An observational study of the direct costs related to hospital admissions, mortality and premature death associated with liver disease in Portugal. BMC Res Notes 2016;9:62. [PMID: 26843372 DOI: 10.1186/s13104-016-1879-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
7 Santos MS, Abreu PH, García-Laencina PJ, Simão A, Carvalho A. A new cluster-based oversampling method for improving survival prediction of hepatocellular carcinoma patients. J Biomed Inform 2015;58:49-59. [PMID: 26423562 DOI: 10.1016/j.jbi.2015.09.012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 21] [Article Influence: 9.6] [Reference Citation Analysis]
8 Colombo GL, Cammà C, Attili AF, Ganga R, Gaeta GB, Brancaccio G, Franzini JM, Volpe M, Turchetti G. Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers. Ther Clin Risk Manag 2015;11:1603-12. [PMID: 26527877 DOI: 10.2147/TCRM.S88208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Simão A. Hepatocellular Carcinoma: Portuguese Data in Chronic Hepatitis B Patients on Antiviral Therapy and Treatment Results With Sorafenib. GE Port J Gastroenterol 2016;23:231-2. [PMID: 28868467 DOI: 10.1016/j.jpge.2016.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat. 2014;21 Suppl 1:60-89. [PMID: 24713006 DOI: 10.1111/jvh.12249] [Cited by in Crossref: 139] [Cited by in F6Publishing: 132] [Article Influence: 17.4] [Reference Citation Analysis]
11 Presa Ramos J, Tavares S, Barreira A, Pimenta JL, Carvalho S, Carrola P, Pinho I. Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience. GE Port J Gastroenterol. [DOI: 10.1159/000522572] [Reference Citation Analysis]
12 Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014;21 Suppl 1:5-33. [PMID: 24713004 DOI: 10.1111/jvh.12247] [Cited by in Crossref: 175] [Cited by in F6Publishing: 157] [Article Influence: 21.9] [Reference Citation Analysis]
13 da Rocha MC, Marinho RT, Rodrigues T. Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012. GE Port J Gastroenterol 2018;25:123-31. [PMID: 29761148 DOI: 10.1159/000484868] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]